Curve Therapeutics CEO Simon Kerry spoke with Amy Brown of Biotech TV on the background, science, and development plans for the Company. Curve CSO Ali Tavassoli also spoke with Amy for a deep dive on the science behind Curve’s mammalian cell-based Microcycle® discovery platform. Simon’s episode is available here while Ali’s is available here.

Awarded in recognition of excellence in research and innovation and contribution to scientific progress Reflects the revolutionary potential of Curve’s gene-encoded Microcycle® platform to unlock the therapeutic potential of intracellular targets Southampton, UK, 25 June 2025 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company building a pipeline of innovative cyclic peptide and […]